Improved blood pressure control in elderly hypertensive patients: Results of the PAPY-65 survey

Drugs and Aging

Volumn 27, Issue 7, 2010, Pages 573-588

  Van Der Niepen, Patricia ^a   Dupont, Alain G ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Antihypertensives, therapeutic use; Blood pressure; Hypertension, treatment.

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ABDOMINAL OBESITY; AGED; ANTHROPOMETRY; ARTICLE; BELGIUM; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; DEMOGRAPHY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; AMBULATORY CARE; CROSS-SECTIONAL STUDY; DRUG COMBINATION; DRUG EFFECT; HEALTH SURVEY; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTIHYPERTENSIVE AGENTS; BELGIUM; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; OBESITY; OBESITY, ABDOMINAL; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 77954169148     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11537350-000000000-00000     Document Type: Article

References (46)

1. Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988- 1991. Hypertension 1995; 25: 305-313
2. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension inmiddle-aged women andmen: the Framingham Heart Study. JAMA 2002; 287: 1003-1010 (Pubitemid 34252058)
3. Kearney PM, WheltonM, Reynolds K, et al. Global burden of hypertension: analysis of world-wide data. Lancet 2005; 365: 217-223
4. Lawes CMM, Vander Hoorn S, Rodgers A., on behalf of the International Society of Hypertension. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371: 1513-1518
5. Beckett NS, Peters R, Fletcher AE, et al., on behalf of the HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898
6. Staessen JA, Gasowski J, Wang J, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 357: 865-872
7. Thijs L, Fagard R, Lijnen P, et al. Why is antihypertensive drug therapy needed in elderly patients with systolodiastolic hypertension? J Hypertens 1994; 12: S25-34
8. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187 (Pubitemid 46924065)
9. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008; 336: 1121-1123
10. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294: 466-472
11. Aronow WS. Treatment of hypertension in the elderly. Geriatrics 2008; 63: 21-25
12. Falaschetti E, Chaudbury M, Mindell J, et al. Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension 2009; 53: 480-486
13. Van der Niepen P, Woestenburg A, Brié H, et al. Effectiveness of Valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). Ann Pharmacother 2009; 43: 849-861
14. Elliott WJ. What factors contribute to the inadequate control of elevated blood pressure? J Clin Hypertens 2008; 10: 20-26
15. Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3221
16. Van der Niepen P, Giot C, van de Borne P. Prevalence of isolated uncontrolled systolic blood pressure among treated hypertensive patients in primary care in Belgium: results of the I-inSyst survey. JHypertens 2008; 26: 2057-2063
17. Kumpusalo E, Pärnänen H, Takala J. Treatment situation of hypertensive patients in Finnish Primary Health Care. Blood Press Suppl 1997; 1: 35-39
18. Westheim A, Klemetsrud T, Tretli S, et al. Blood pressure levels in treated hypertensive patients in general practice in Norway. Blood Press 2001; 10: 37-42
19. Fagard RH, Van Den EndenM, Leeman M, et al. Survey on treatment of hypertension and implementation of World Health Organization/International Society of Hypertension risk stratification in primary care in Belgium. J Hypertens 2002; 20: 1297-1302
20. Sharma AM, Wittchen HU, KirchW, et al., on behalf of the HYDRA Study Group. High prevalence and poor control of hypertension in primary care: cross-sectional study. J Hypertens 2004; 22: 479-486
21. Chamontin B, Poggi L, Lang T, et al. Prevalence, treatment and control of hypertension in the French population: data from a survey on high blood pressure in general practice. Am J Hypertens 2001; 19: 1727-1732
22. Efstratopoulos A, Voyaki S, Baltas A, et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006; 19: 53-60
23. Psaty BM, Manolio TA, Smith NL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: the Cardiovascular Health Study. Arch Intern Med 2002; 162: 2325-2332
24. Prencipe M, Casini AR, Santini M, et al. Prevalence, awareness, treatment and control of hypertension in the elderly: results from a population survey. JHum Hypertens 2000; 14: 825-830
25. Banegas JR, Rodriguez-Artalejo F, Ruilope LM, et al. Hypertension magnitude and management in the elderly population of Spain. J Hypertens 2002; 20: 2157-2164
26. Brindel P, Hanon O, Dartigues J-F, et al., on behalf of the Three City Study Investigators. Prevalence, awareness, treatment, and control in the elderly: the Three City study. J Hypertens 2006; 24: 51-58
27. De Backer G, Myny K, De Henauw S, et al. Prevalence, awareness, treatment and control of arterial hypertension in an elderly population in Belgium. J Hum Hypertens 1998; 12: 701-706 (Pubitemid 28495127)
28. Mancia G, Bombelli M, Lanzarotti A, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertens 2000; 36: 594-599
29. Kannel WB, Gordon T, Schwartz MJ. Systolic versus diastolic blood pressure and risk of coronary heart disease. Am J Cardiol 1971; 17: 335-346
30. Psaty BM, Furberg CD, Kuller LH, et al. The association between level of blood pressure and the risk of myocardial infarction, stroke, and total mortality: the Cardiovascular Health Study. Arch Intern Med 2001; 161: 1183-1192
31. Pepe S, Lakatta EG. Aging hearts and vessels: masters of adaptation and survival. Cardiovasc Res 2005; 66: 190-193
32. Safar ME, Smulyan H. Atherosclerosis, arterial stiffness and antihypertensive drug therapy.Adv Cardiol 2007; 44: 331-351
33. Ostchega Y, Dillon CF, Hughes JP, et al. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1998-2004. J Am Geriatr Soc 2007; 55: 1056-1065
34. Costanzo S, Di Castelnuovo A, Zito F, et al., on behalf of the European Collaborative Group of the IMMIDIET project. Prevalence, awareness, treatment and control of hypertension in healthy unrelated male-female pairs of European regions: the dietary habit profile in European communities with different risk of myocardial infarctionthe impact of migration as a model of gene-environment interaction project. J Hypertens 2008; 26: 2303-2311
35. Sullivan LM, Massaro JM, D'Agostino RB. Presentations of multivariate data for clinical use: the Framingham Risk score functions. Stat Med 2004; 23: 1631-1660
36. Redon J, Cea-Calvo L, Lozano JV, et al., on behalf of the ERIC-HTA 2003 Study Investigators. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study. J Hypertens 2006; 24: 663-669
37. Canoy D, Luben R, Welch A, et al. Fat distribution, body mass index and blood pressure in 22,090 men and women in the Norfolk cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Norfolk) study. J Hypertens 2004; 22: 2067-2074
38. Prospective Studies Collaboration. Body mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096
39. Redon J, Cea-Calvo L, Moreno B, et al., on behalf of the investigators of the PREV-ICTUS Study. Independent impact of obesity and fat distribution prevalence in hypertension and control in the elderly. J Hypertens 2008; 26: 1757-1764
40. Freemantle N, Holmes J, Hockey A, et al. How strong is the association between abdominal obesity and the incidence of type 2 diabetes? Int J Clin Pract 2008; 62: 1391-1396
41. Gu Q, Paulose-Ram R, Dillon C, et al. Antihypertensive medication use among US adults with hypertension. Circulation 2006; 113: 213-221
42. Redò n J, Cifkova R, Laurent S, et al. Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens 2009; 27: 441-451
43. Redò n J, Cifkova R, Laurent S, et al., on behalf of the Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European Society of Hypertension position statement. J Hypertens 2008; 26: 1891-1900
44. Laragh J. Abstract, closing summary, and table of contents for Laragh's 25 lessons in pathophysiology and 12 clinical pearls for treating hypertension. Am J Hypertens 2001; 14: 1173-1174
45. Duprez DA. Systolic hypertension in the elderly: addressing an unmet need. Am J Med 2008; 121: 179-184
46. Emberson J, Whincup P, Morris R, et al. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J 2004; 25: 484-491